10
views
0
recommends
+1 Recommend
2 collections
    0
    shares

          The flagship journal of the Society for Endocrinology. Learn more

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      An undiagnosed TSH-secreting pituitary macroadenoma found during pregnancy

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Thyroid stimulating hormone (TSH)-secreting pituitary adenoma (TSHoma) is an uncommon cause of thyrotoxicosis, and is even rarer when found during pregnancy. Our patient presented with thyrotoxicosis accompanied by an inappropriately normal TSH level at 10 weeks of gestation during work-up of surgical termination of pregnancy (STOP). Subsequent investigations performed after STOP confirmed the presence of a TSH-secreting pituitary macroadenoma. She was initially treated with anti-thyroid drugs for biochemical control, followed by trans-sphenoidal surgery after STOP had been performed. Her thyroid function completely normalized after the trans-sphenoidal surgery. Our case illustrated the importance of recognizing the syndrome of inappropriate TSH secretion and highlighted several pregnancy-related aspects in the diagnosis and management of TSHoma during pregnancy.

          Learning points
          • This case report illustrates the need to raise awareness in recognizing the syndrome of inappropriate TSH secretion.

          • Illustrate the different hormone tests available for reaching the diagnosis of TSH-secreting pituitary adenoma.

          • Highlight the physiological changes in the thyroid status during pregnancy and the importance of using trimester-specific reference ranges for assessment of thyroid function during pregnancy.

          • Describe the challenges in the management of TSH-secreting pituitary adenoma during pregnancy.

          Related collections

          Most cited references12

          • Record: found
          • Abstract: found
          • Article: not found

          2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum.

          Thyroid disease in pregnancy is a common clinical problem. Since the guidelines for the management of these disorders by the American Thyroid Association (ATA) were first published in 2011, significant clinical and scientific advances have occurred in the field. The aim of these guidelines is to inform clinicians, patients, researchers, and health policy makers on published evidence relating to the diagnosis and management of thyroid disease in women during pregnancy, preconception, and the postpartum period.
            • Record: found
            • Abstract: found
            • Article: not found

            Thyroid disease in pregnancy: new insights in diagnosis and clinical management

            Thyroid dysfunction is associated with adverse obstetric and child development outcomes. Here, Tim Korevaar and colleagues put studies from the past decade on reference ranges, thyroid dysfunction determinants, adverse outcome risks and treatment options into perspective.
              • Record: found
              • Abstract: found
              • Article: not found

              Incidence of pituitary adenomas in Northern Finland in 1992-2007.

              Data on the incidence of pituitary adenomas (PAs) are scant and outdated. A population-based regional cohort with thorough case identification was used to evaluate the incidence of clinically detected PAs in the era of magnetic resonance imaging. The objective of the study was to describe the age- and sex-specific incidence of all PA subgroups, with data on incidentally found PAs, pituitary apoplexies, and time trends. This was a retrospective descriptive analysis of PA patients diagnosed during 1992-2007 in Northern Finland (NFi). World Health Organization 2000-standardized incidence rates (SIRs) of PAs per 100,000 were measured. The final cohort consisted of 355 PAs. The incidence rates of the Oulu University Hospital regional district were used as a reference to assess the applicability of our case finding over the rest of NFi. Incidence rates of all PA subgroups except microprolactinomas were statistically equal between these areas; thus, all presented SIRs are based on the NFi's cohort except Oulu University Hospital regional district-based prolactinomas and PAs overall. Overall SIR of PAs was higher (4.0 per 100,000) than in previous reports. Prolactinomas had the highest SIR: 2.2 per 100,000, followed by clinically nonfunctioning PAs (1.0) and GH-secreting (0.34), ACTH-secreting (0.17), and TSH-secreting (0.03) PAs. The gender-specific SIR was 2.2 per 100,000 in males and 5.9 per 100,000 in females. Pituitary apoplexy occurred as a presenting symptom in 11% of clinically nonfunctioning PA patients. The SIR of incidentally discovered PAs increased significantly from 1992-1999 to 2000-2007 (0.59 to 1.6, respectively; P 0.05).

                Author and article information

                Journal
                Endocrinol Diabetes Metab Case Rep
                Endocrinol Diabetes Metab Case Rep
                EDM
                Endocrinology, Diabetes & Metabolism Case Reports
                Bioscientifica Ltd (Bristol )
                2052-0573
                16 March 2021
                2021
                : 2021
                : 20-0210
                Affiliations
                [1 ]Department of Medicine , University of Hong Kong, Hong Kong SAR, China
                Author notes
                Correspondence should be addressed to C-H Lee; Email: pchlee@ 123456hku.hk
                Article
                EDM200210
                10.1530/EDM-20-0210
                7983472
                658aca7b-26c5-4ca8-91e4-57f430ef71ee
                © 2021 The authors

                This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License..

                History
                : 23 January 2021
                : 22 February 2021
                Categories
                Adult
                Pregnant adult
                Female
                Asian - Chinese
                Hong Kong
                Pituitary
                Pituitary
                Obstetrics
                Error in Diagnosis/Pitfalls and Caveats
                Error in Diagnosis/Pitfalls and Caveats

                adult,pregnant adult,female,asian - chinese,hong kong,pituitary,obstetrics,error in diagnosis/pitfalls and caveats,march,2021

                Comments

                Comment on this article

                Related Documents Log